The Uromigos Episode 83: Is Cabozantinib the New Standard of Care in Papillary Renal Cancer?

By The Uromigos - Last Updated: February 14, 2021

Monty Pal discusses his randomized phase 2 study of cabozantinib in papillary renal cancer.

Post Tags:Uromigos-Kidney Cancer

Related Podcasts

Episode 406: Drug Development in China: Part 1 of 2
Episode 405: The Good News About Cancer Podcast
Episode 404: 177 Lu-PSMA Pre-Chemotherapy in mCRPC
Uromigos-Prostate Cancer
Episode 403: ADCs in Bladder Cancer Part 2
Uromigos-Bladder Cancer
Episode 401: ADCs in Bladder Cancer Part 1
Uromigos-Bladder Cancer
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |